C. Gersbach
Molecular Biology · 2013–2019
A researcher in the Science corpus: 8 papers; trusts 11 researchers and is trusted by 12 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 311 citations into it; #4,337 of 17,773 by trust here, #3,138 by citations
- Genetics — 70 citations into it; #4,414 of 6,854 by trust here, #1,649 by citations
- Oncology — 14 citations into it
Whom C. Gersbach trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts C. Gersbach overall
Papers from C. Gersbach's perspective
Ordered by how strongly the researchers C. Gersbach trusts endorse each paper. Same corpus, a different order for every researcher.
- Model-based Analysis of ChIP-Seq (MACS)
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation (Cell)
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
- SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. (Genes & Development)
- The Sequence Alignment/Map format and SAMtools (Bioinform.)
- CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes (Science)
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA (Nature)
- The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli (Nucleic Acids Research)
Their papers
- RNA-guided gene activation by CRISPR-Cas9-based transcription factors (2013) — 1,302 citations
- Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers (2015) — 1,755 citations
- ZFN, TALEN and CRISPR/Cas-based methods for genome engineering (2013) — 3,618 citations
- Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements (2015) — 957 citations
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy (2016) — 1,069 citations
- A light-inducible CRISPR/Cas9 system for control of endogenous gene activation (2015) — 606 citations
- The next generation of CRISPR–Cas technologies and applications (2019) — 1,213 citations
- Genome-editing Technologies for Gene and Cell Therapy (2016) — 623 citations